David W. Boykin
55Patents
10h-index
29Co-inventors
78Inventor score
Filing activity: May 6, 1994 → Dec 20, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5935982A | Methods of treating retroviral infection and compounds useful therefor | Chemistry; Metallurgy | 61 | Expired |
| US5643935A | Method of combatting infectious diseases using dicationic bis-benzimidazoles | Human Necessities | 29 | Expired |
| US5521189A | Methods of treating pneumocystis carinii pneumonia | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5594138A | Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5602172A | Methods of inhibiting Pneumocystis carinii pneumonia, Giardia lamblia, and Cryptosporidium and compounds useful therefor | Emerging Cross-Sectional Technologies | 17 | Expired |
| US5723288A | Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans, and kits useful therefor | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6613787B2 | Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind in the DNA minor groove as a dimer | Chemistry; Metallurgy | 15 | Expired |
| US5667975A | Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6326395A | Antifungal activity of dicationic molecules | Human Necessities | 12 | Expired |
| US5723495A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 10 | Expired |
| US5843980A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7517893B2 | Bichalcophenes and their prodrugs as antiprotozoal agents | Emerging Cross-Sectional Technologies | 10 | Active |
| US6008247A | 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents | Chemistry; Metallurgy | 9 | Expired |
| US5668166A | Methods of inhibiting pneumocystis carinii pneumonia and compounds useful therefor | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5668167A | Methods of treating microbial infections | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5627184A | Methods of treating Giardia lamblia | Emerging Cross-Sectional Technologies | 7 | Expired |
| US5686456A | Methods of treating pneumocystis carinii pneumonia | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5606058A | Compounds for the treatment of pneumocystis carinii Pneumonia, Giardia Lamblia, and Cryptospordium parnum | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5622955A | Methods of treating cryptosporidium parvum | Emerging Cross-Sectional Technologies | 6 | Expired |
| US5639755A | Methods of combatting infectious diseases using dicationic bis-benzimidazoles | Human Necessities | 6 | Expired |
| US6127554A | 2,4-bis[(4-amidino)phenyl]furans as anti-Pneumocystis carinii agents | Chemistry; Metallurgy | 5 | Expired |
| US6867227B2 | Compounds that exhibit specific molecular recognition of mixed nucleic acid sequences and bind the DNA minor groove as a dimer | Chemistry; Metallurgy | 5 | Expired |
| US6025398A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6649652B2 | Prodrugs for antimicrobial amidines | Emerging Cross-Sectional Technologies | 5 | Expired |
| US6214883A | Benzamidoxime prodrugs as antipneumocystic agents | Emerging Cross-Sectional Technologies | 4 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.